As filed with the Securities and Exchange Commission on May 11, 2023
Registration Statement No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
Trevi Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 45-0834299 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
195 Church Street, 16th Floor
New Haven, CT 06510
(Address of principal executive offices)
2019 Stock Incentive Plan
2019 Employee Stock Purchase Plan
(Full title of the plan)
Jennifer Good
President and Chief Executive Officer
Trevi Therapeutics, Inc.
195 Church Street, 16th Floor
New Haven, Connecticut 06510
(Name and address of agent for service)
(203) 304-2499
(Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
|
|
|
| |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
|
|
|
|
|
|
|
Emerging growth company |
| ☒ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☒
Statement of Incorporation by Reference
This Registration Statement on Form S-8, relating to the 2019 Stock Incentive Plan and the 2019 Employee Stock Purchase Plan of Trevi Therapeutics, Inc. (the “Registrant”), is being filed for the purpose of registering additional securities of the same class as other securities for which a Registration Statement on Form S-8 has previously been filed and is effective. Pursuant to General Instruction E to Form S-8, except as otherwise set forth below, this Registration Statement incorporates by reference (i) the contents of the Registration Statement on Form S-8, File No. 333-231260, relating to the 2012 Stock Incentive Plan, as amended, of the Registrant, the 2019 Stock Incentive Plan of the Registrant (the “2019 Plan”), and the 2019 Employee Stock Purchase Plan of the Registrant (the “2019 ESPP”), filed by the Registrant with the Securities and Exchange Commission on May 7, 2019, (ii) the contents of the Registration Statement on Form S-8, File No. 333-237193, relating to the 2019 Plan and the 2019 ESPP, filed by the Registrant with the Securities and Exchange Commission on March 16, 2020, (iii) the contents of the Registration Statement on Form S-8, File No. 333-257729, relating to the 2019 Plan and the 2019 ESPP, filed by the Registrant with the Securities and Exchange Commission on July 7, 2021, and (iv) the contents of the Registration Statement on Form S-8, File No. 333-264615, relating to the 2019 Plan and the 2019 ESPP, filed by the Registrant with the Securities and Exchange Commission on May 2, 2022.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
The following exhibits are incorporated herein by reference:
____________
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in New Haven, Connecticut, on this 11th day of May, 2023.
| Trevi Therapeutics, Inc. | ||
By: | /s/ Lisa Delfini | ||
Name: | Lisa Delfini | ||
Title: | Chief Financial Officer | ||
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers and directors of Trevi Therapeutics, Inc., hereby severally constitute and appoint Jennifer Good and Lisa Delfini, and each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names in the capacities indicated below, the registration statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as officers and directors to enable Trevi Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorneys, or any of them, to said registration statement and any and all amendments thereto.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | ||
|
| |||
/s/ Jennifer Good | President and Chief Executive Officer, Director (Principal Executive Officer) | May 11, 2023 | ||
Jennifer Good |
|
| ||
|
| |||
/s/ Lisa Delfini | Chief Financial Officer (Principal Financial Officer) | May 11, 2023 | ||
Lisa Delfini |
|
| ||
|
| |||
/s/ Christopher Galletta | Controller (Principal Accounting Officer) | May 11, 2023 | ||
Christopher Galletta |
|
| ||
|
|
|
|
|
/s/ David Meeker, M.D. | Chairman of the Board | May 11, 2023 | ||
David Meeker, M.D. |
|
| ||
|
| |||
/s/ James V. Cassella, Ph.D. | Director | May 11, 2023 | ||
James V. Cassella, Ph.D. |
|
| ||
|
| |||
/s/ Dominick Colangelo | Director | May 11, 2023 | ||
Dominick Colangelo |
|
| ||
|
| |||
/s/ Michael Heffernan | Director | May 11, 2023 | ||
Michael Heffernan |
|
| ||
|
| |||
/s/ Edward Mathers | Director | May 11, 2023 | ||
Edward Mathers |
|
| ||
|
| |||
/s/ Anne VanLent | Director | May 11, 2023 | ||
Anne VanLent |
|
| ||
|
|
